David Risinger
Stock Analyst at Leerink Partners
(4.99)
# 30
Out of 5,124 analysts
1061
Total ratings
65.4%
Success rate
32.7%
Average return
Main Sectors:
Stocks Rated by David Risinger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics | Downgraded: Hold | $110 → $117 | $102.92 | +13.68% | 40 | Nov 6, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $90 | $49.70 | +81.09% | 4 | Nov 5, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $279 → $325 | $293.30 | +10.81% | 75 | Nov 2, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,316 → $1,508 | $1,411.95 | +6.80% | 123 | Nov 2, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $835 → $997 | $919.96 | +8.37% | 62 | Nov 2, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $272 | $282.11 | -3.58% | 57 | Oct 27, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | n/a | $104.56 | - | 16 | Oct 27, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | n/a | $550.87 | - | 45 | Oct 27, 2026 | |
| ANAB AnaptysBio | Reiterated: Buy | $81 | $47.97 | +68.86% | 36 | Oct 21, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $60 | $21.89 | +174.10% | 14 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.78 | +124.72% | 11 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 → $59 | $62.14 | -5.05% | 72 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $3.25 | +176.92% | 1 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 | $16.68 | +121.82% | 1 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $24 | $3.97 | +504.53% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $465.23 | - | 42 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $85.76 | - | 58 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $32 | $40.67 | -21.32% | 47 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $29.23 | -11.05% | 90 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $67.53 | n/a | 27 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $48.12 | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.65 | n/a | 5 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $44 | $21.41 | n/a | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $27 → $23 | $269.00 | n/a | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $37.75 | n/a | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.68 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.43 | n/a | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 | $169.32 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.69 | n/a | 1 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $33 | $13.85 | n/a | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $176 | $243.55 | n/a | 12 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 → $22 | $34.61 | n/a | 15 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $148.76 | n/a | 34 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $16 | $20.49 | n/a | 24 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $45 | $16.95 | n/a | 19 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49.40 | $11.88 | n/a | 32 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $22 | $46.17 | n/a | 19 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $167 → $41 | $26.84 | n/a | 8 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $167 → $174 | $82.32 | n/a | 16 | Nov 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $51 | $68.77 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $3 | $21.28 | n/a | 4 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $345.76 | n/a | 2 | Nov 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $119.79 | n/a | 3 | Sep 21, 2012 |
Halozyme Therapeutics
Nov 6, 2026
Downgraded: Hold
Price Target: $110 → $117
Current: $102.92
Upside: +13.68%
First Tracks Biotherapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $90
Current: $49.70
Upside: +81.09%
AbbVie
Nov 2, 2026
Reiterated: Buy
Price Target: $279 → $325
Current: $293.30
Upside: +10.81%
Eli Lilly and Company
Nov 2, 2026
Reiterated: Buy
Price Target: $1,316 → $1,508
Current: $1,411.95
Upside: +6.80%
Regeneron Pharmaceuticals
Nov 2, 2026
Reiterated: Hold
Price Target: $835 → $997
Current: $919.96
Upside: +8.37%
Johnson & Johnson
Oct 27, 2026
Reiterated: Buy
Price Target: $272
Current: $282.11
Upside: -3.58%
Oruka Therapeutics
Oct 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $104.56
Upside: -
Vertex Pharmaceuticals
Oct 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $550.87
Upside: -
AnaptysBio
Oct 21, 2026
Reiterated: Buy
Price Target: $81
Current: $47.97
Upside: +68.86%
Tectonic Therapeutic
Oct 15, 2026
Reiterated: Buy
Price Target: $60
Current: $21.89
Upside: +174.10%
Oct 9, 2026
Reiterated: Buy
Price Target: $4
Current: $1.78
Upside: +124.72%
Oct 7, 2026
Reiterated: Hold
Price Target: $60 → $59
Current: $62.14
Upside: -5.05%
Sep 18, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $3.25
Upside: +176.92%
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $16.68
Upside: +121.82%
May 8, 2026
Reiterated: Buy
Price Target: $30 → $24
Current: $3.97
Upside: +504.53%
Jan 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $465.23
Upside: -
Dec 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $85.76
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $22 → $32
Current: $40.67
Upside: -21.32%
Dec 9, 2025
Reiterated: Hold
Price Target: $26
Current: $29.23
Upside: -11.05%
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $67.53
Upside: n/a
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $48.12
Upside: n/a
Aug 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.65
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $60 → $44
Current: $21.41
Upside: n/a
Apr 16, 2025
Reiterated: Sell
Price Target: $27 → $23
Current: $269.00
Upside: n/a
Feb 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $37.75
Upside: n/a
Jan 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.68
Upside: n/a
May 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.43
Upside: n/a
Apr 28, 2023
Reiterated: Hold
Price Target: $91
Current: $169.32
Upside: n/a
Mar 14, 2023
Reiterated: Buy
Price Target: n/a
Current: $9.69
Upside: n/a
Jun 11, 2021
Initiated Coverage: Hold
Price Target: $33
Current: $13.85
Upside: n/a
May 21, 2021
Reiterated: Hold
Price Target: $176
Current: $243.55
Upside: n/a
May 13, 2021
Reiterated: Sell
Price Target: $20 → $22
Current: $34.61
Upside: n/a
Apr 1, 2021
Reiterated: Buy
Price Target: $90
Current: $148.76
Upside: n/a
Mar 10, 2021
Reiterated: Hold
Price Target: $18 → $16
Current: $20.49
Upside: n/a
Mar 5, 2021
Reiterated: Hold
Price Target: $53 → $45
Current: $16.95
Upside: n/a
Feb 26, 2021
Reiterated: Hold
Price Target: $49.40
Current: $11.88
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $16 → $22
Current: $46.17
Upside: n/a
Nov 23, 2020
Reiterated: Buy
Price Target: $167 → $41
Current: $26.84
Upside: n/a
Nov 13, 2020
Reiterated: Hold
Price Target: $167 → $174
Current: $82.32
Upside: n/a
Jul 13, 2020
Initiated Coverage: Hold
Price Target: $51
Current: $68.77
Upside: n/a
Apr 2, 2020
Reiterated: Hold
Price Target: $18 → $3
Current: $21.28
Upside: n/a
Nov 16, 2015
Upgraded: Hold
Price Target: n/a
Current: $345.76
Upside: n/a
Sep 21, 2012
Reiterated: Buy
Price Target: $36
Current: $119.79
Upside: n/a